Earnings History Data for Harmony Biosciences Holdings, Inc. (HRMY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-02-2024	PM		HRMY	Harmony Biosciences Holdings, Inc.	1,980	0.45	0.74	1.01	Harmony Biosciences Non-GAAP EPS of $0.73 misses by $0.18, revenue of $168.4M in-line [2/22/2024 7:32 AM]	31.45	-1.55 (-4.70%)	32.04	-0.96 (-2.91%)	18.61 - 46.97	723,451	300,000	1,118
Harmony Biosciences Q4 2023 Earnings Preview [2/21/2024 10:48 AM] Harmony Biosciences Non-GAAP EPS of $0.73 misses by $0.18, revenue of $168.4M in-line [2/22/2024 7:32 AM]
31-10-2023	PM		HRMY	Harmony Biosciences Holdings, Inc.	1,170	0.63	0.67	0.95	Harmony Biosciences Non-GAAP EPS of $0.97 beats by $0.16, revenue of $160.3M beats by $11.69M [10/31/2023 7:34 AM]	23.53	3.82 (19.38%)	21.25	1.54 (7.81%)	18.61 - 62.08	1,477,495	880,000	1,639
Harmony Biosciences Non-GAAP EPS of $0.97 beats by $0.16, revenue of $160.3M beats by $11.69M [10/31/2023 7:34 AM]
01-08-2023	PM		HRMY	Harmony Biosciences Holdings, Inc.	2,110	0.56	0.62	0.57	Harmony Biosciences Non-GAAP EPS of $0.76 beats by $0.02, revenue of $134.2M misses by $7.84M [8/1/2023 7:41 AM]	33.98	-1.39 (-3.93%)	36.00	0.63 (1.78%)	29.81 - 62.08	1,106,995	440,000	2,272
Harmony Biosciences Non-GAAP EPS of $0.76 beats by $0.02, revenue of $134.2M misses by $7.84M [8/1/2023 7:41 AM] Harmony Biosciences announces $125M buyback [8/1/2023 8:03 AM]
02-05-2023	PM	7:30 AM ET (May 2)	HRMY	Harmony Biosciences Holdings, Inc.	1,880	0.48	0.44	0.51	Harmony Biosciences Non-GAAP EPS of $0.66 beats by $0.10, revenue of $119.13M beats by $2.94M [5/2/2023 7:37 AM]	33.47	0.71 (2.17%)	35.55	2.79 (8.52%)	29.81 - 62.08	1,602,228	650,000	15,774
Harmony Biosciences Non-GAAP EPS of $0.66 beats by $0.10, revenue of $119.13M beats by $2.94M [5/2/2023 7:37 AM]
21-02-2023	PM	7:30 AM ET (Feb 21)	HRMY	Harmony Biosciences Holdings, Inc.	2,890	1.01	0.54	0.63	Harmony Biosciences Non-GAAP EPS of $1.01 beats by $0.23, revenue of $128.31M beats by $0.97M [2/21/2023 7:31 AM]	43.73	-5.55 (-11.25%)	51.00	1.73 (3.51%)	33.04 - 62.08	1,802,376	530,000	2,253
Harmony Biosciences Non-GAAP EPS of $1.01 beats by $0.23, revenue of $128.31M beats by $0.97M [2/21/2023 7:31 AM]
01-11-2022	PM	7:30 AM ET (Nov 1)	HRMY	Harmony Biosciences Holdings, Inc.	3,100	0.95	0.10	0.43	Harmony Biosciences GAAP EPS of $1.44 beats by $1.34, revenue of $117.2M beats by $3.66M [11/1/2022 7:36 AM]	59.24	7.24 (13.92%)	55.00	3.00 (5.77%)	31.54 - 59.27	1,208,709	400,000	609
Harmony Biosciences GAAP EPS of $1.44 beats by $1.34, revenue of $117.2M beats by $3.66M [11/1/2022 7:36 AM] Harmony sees positive mid-stage data for daytime sleepiness drug in new indication [11/1/2022 9:17 AM] Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates [Nov-01-22 07:30AM] HARMONY BIOSCIENCES ANNOUNCES TOPLINE RESULTS FROM PHASE 2 PROOF-OF-CONCEPT STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME [Nov-01-22 07:20AM]
02-08-2022	PM	7:30 AM ET (Aug 2)	HRMY	Harmony Biosciences Holdings, Inc.	3,010	0.57	0.39	0.54	Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M [8/2/2022 7:42 AM]	55.30	6.08 (12.34%)	54.10	4.87 (9.89%)	25.94 - 57.13	1,777,236	430,000	3,924
Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M [8/2/2022 7:42 AM] Harmony Biosciences Reports Second Quarter 2022 Financial Results and Business Updates [Aug-02-22 07:30AM]
03-05-2022	PM	7:30 AM ET (May 3)	HRMY	Harmony Biosciences	2,710	0.51	0.25	0.00	Harmony Biosciences Non-GAAP EPS of $0.51 beats by $0.05, revenue of $85.3M misses by $3.25M [5/3/2022 7:37 AM]	37.11	-7.99 (-17.71%)	44.00	-1.10 (-2.44%)	25.09 - 54.00	2,270,353	476,743	230
Harmony Biosciences Non-GAAP EPS of $0.51 beats by $0.05, revenue of $85.3M misses by $3.25M [5/3/2022 7:37 AM] Harmony Biosciences Getting the Big Money Treatment [May-02-22 06:14AM] Harmony Biosciences Reports First Quarter 2022 Financial Results and Business Updates [May-03-22 07:30AM] Harmony Biosciences Holdings, Inc. (HRMY) Beats Q1 Earnings Estimates [May-03-22 08:55AM]
28-02-2022	PM	7:30 AM ET (Feb 22)	HRMY	Harmony Biosciences Holdings, Inc.	2,190	0.63	0.34	0.25	Harmony Biosciences Non-GAAP EPS of $0.63 beats by $0.12, revenue of $91.21M beats by $1.68M [2/28/2022 7:32 AM]	40.38	2.45 (6.46%)	37.93	0.0 (0.00%)	25.09 - 45.89	659,925	220,000	2,296
Harmony Biosciences Non-GAAP EPS of $0.63 beats by $0.12, revenue of $91.21M beats by $1.68M [2/28/2022 7:32 AM] Harmony Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates [Feb-28-22 07:30AM] Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Surpass Estimates [Feb-28-22 08:55AM] Harmony Biosciences Holdings, Inc. (HRMY) Q4 2021 Earnings Call Transcript [Feb-28-22 01:30PM]
09-11-2021	PM	8:00 AM ET (Nov 9)	HRMY	Harmony Biosciences Holdings, Inc.	2,420	0.43	0.23	-0.14	Harmony Biosciences EPS misses by $0.01, beats on revenue [11/9/2021 7:48 AM]	42.24	-0.34 (-0.80%)	41.80	-0.78 (-1.83%)	25.09 - 52.74	292,045	340,000	712
Harmony Biosciences EPS misses by $0.01, beats on revenue [11/9/2021 7:48 AM] Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates [Nov-09-21 07:30AM] Harmony Biosciences Holdings, Inc. (HRMY) Tops Q3 Earnings and Revenue Estimates [Nov-09-21 08:55AM]
10-08-2021	PM	8:00 AM ET (Aug 10)	HRMY	Harmony Biosciences Holdings, Inc.	1,530	0.54	0.19	0.00	Harmony Biosciences EPS beats by $0.07, beats on revenue [8/10/2021 8:09 AM]	30.16	3.39 (12.66%)	30.16	0.0 (0.00%)	25.09 - 52.74	514,629	210,000	787
Harmony Biosciences to acquire neurological disease-focused compound from ConSynance [8/9/2021 9:04 AM] Harmony Biosciences EPS beats by $0.07, beats on revenue [8/10/2021 8:09 AM] Harmony Biosciences rises on earnings beat and $330M financing from Blackstone [8/10/2021 10:19 AM] Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases [Aug-09-21 08:05AM] Harmony Biosciences And Blackstone Enter Into Strategic Financing Collaboration [Aug-10-21 07:30AM] Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates [Aug-10-21 08:00AM]
11-05-2021	PM	8:00 AM ET (May 11)	HRMY	Harmony Biosciences Holdings, Inc.	1,580	0.38	-0.01	0.00	Harmony Biosciences EPS beats by $0.39, beats on revenue [5/11/2021 8:19 AM]	25.96	-0.84 (-3.13%)	0.0	0.0 (0.00%)	25.65 - 52.74	373,242	120,000	0
Harmony Biosciences EPS beats by $0.39, beats on revenue [5/11/2021 8:19 AM] Drug/Biotech Stock Q1 Earnings on May 10: CPRX, PRTA & More [May-10-21 10:40AM] Harmony Biosciences Holdings Inc to Host Earnings Call [May-11-21 05:45AM] Harmony Biosciences Reports First Quarter 2021 Results and Business Updates [May-11-21 08:00AM] Harmony Biosciences Holdings, Inc. (HRMY) Q1 2021 Earnings Call Transcript [May-11-21 02:00PM]
25-03-2021	PM	8:00 AM ET (Mar 25)	HRMY	Harmony Biosciences Holdings, Inc.	1,660	0.25	0.11	0.00	Harmony Biosciences EPS beats by $0.20, beats on revenue [3/25/2021 9:08 AM]	29.62	0.87 (3.03%)	0.0	0.0 (0.00%)	27.08 - 52.74	148,900	260,000	0
Harmony Biosciences EPS beats by $0.20, beats on revenue [3/25/2021 9:08 AM] Harmony Biosciences Holdings Inc to Host Earnings Call [Mar-25-21 06:30AM] Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates [Mar-25-21 08:00AM] Harmony Biosciences Holdings, Inc. (HRMY) Q4 2020 Earnings Call Transcript [Mar-25-21 12:00PM]
12-11-2020	PM		HRMY	Harmony Biosciences Holdings, Inc.	3,270	-0.14	0.00	0.00	Harmony Biosciences beats on revenue [11/12/2020 8:04 AM]	43.86	-3.62 (-7.62%)	47.43	-0.04 (-0.08%)	28.96 - 52.74	393,144	142,635	957